Lipid antigen presentation in the immune system: Lessons learned from CD1d knockout mice

Immunological Reviews

Volumn 169, Issue , 1999, Pages 31-44

  Hong, Seokmann ^a   Scherer, David C ^a   Singh, Nagendra ^a   Mendiratta, Sanjeev K ^a   Serizawa, Isao ^b   Koezuka, Yasuhiko ^b   Van Kaer, Luc ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CYTOKINE; GALACTOSYLCERAMIDE; GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 4; LIPID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; HELPER CELL; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; METASTASIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; AUTOIMMUNE DISEASES; CYTOTOXICITY, IMMUNOLOGIC; GLYCOLIPIDS; HUMANS; KILLER CELLS, NATURAL; LIPIDS; MICE; MICE, KNOCKOUT; TH1 CELLS; TH2 CELLS;

EID: 0032775884     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01304.x     Document Type: Review

References (122)

1. 1. Porcelli SA. The CD1 family; a third lineage of antigen-presenting molecules. Adv Immunol 1995;59:1-98.
2. 2. Bendelac A, Rivera MN, Park S-H, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997;15:535-562.
3. 3. Brossay L, Burdin N, Tangri S, Kronenberg M. Antigen-presenting function of mouse CD1: one molecule with two different kinds of antigenic ligands. Immunol Rev 1998;163:139-150.
4. 4. Porcelli SA, Segelke BW, Sugita M, Wilson IA, Brenner MB. The CD1 family of lipid antigen-presenting molecules. Immunol Today 1998;19:362-368.
5. 5. Sieling PA. A broader role for CD1 in the spectrum of immune responses. The Immunologist 1998;6:112-115.
6. 6. Hughes AL. Evolutionary origin and diversification of the mammalian CD1 antigen genes. Mol Biol Evol 1991;8:185-201.
7. 7. Ichimiya S, Kikuchi K, Matsuura A. Structural analysis of the rat homologue of CD1. Evidence for evolutionary conservation of the CD1D class and widespread transcription by rat cells. J Immunol 1994;153:1112-1123.
8. 8. Ferguson ED, Dutia BM, Hein WR, Hopkins J. The sheep CD1 gene family contains at least four CD1B homologues. Immunogenetics 1996;44:86-96.
9. 9. Martin LH, Calabi, F, Lefebvre FA, Bilsland CA, Milstein C. Structure and expression of the human thymocyte antigens CD1a, CD1b, and CD1c. Proc Natl Acad Sci USA 1987;84:9189-9193.
10. 10. Van Kaer L, et al. Recognition of MHC TL gene products by γδ T cells. Immunol Rev 1991;120:89-115.
11. 11. Calabi F, Jarvis JM, Martin L, Milstein C. Two classes of CD1 genes. Eur J Immunol 1989;19:285-292.
12. 12. Bradbury A, Belt KT, Neri TM, Milstein C, Calabi F. Mouse CD1 is distinct from and coexists with TL in the same thymus. EMBO J 1988;7:3081-3086.
13. 13. Bleicher PA, Balk SP, Hagen SJ, Blumberg RS, Flotte TJ, Terhorst C. Expression of murine CD1 on gastrointestinal epithelium. Science 1990;250:679-682.
14. 14. Bradbury A, Calabi F, Milstein C. Expression of CD1 in the mouse thymus. Eur J Immunol 1990;20:1831-1836.
15. 15. Balk SP, Bleicher PA, Terhorst C. Isolation and expression of cDNA encoding the murine homologues of CD1. J Immunol 1991;146:768-774.
16. 16. Brossay L, et al. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol 1997;159:1216-1214.
17. 2-microglobulin-dependent and independent forms. J Immunol 1998;161:1710-1717.
18. 18. Mandal M, et al. Tissue distribution, regulation and intracellular localization of murine CD1 molecules. Mol Immunol 1998;35:525-536.
19. 19. Roark JH, Park S-H, Jayawardena J, Kavita U, Shannon M, Bendelac A. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J Immunol 1998;160:3121-3127.
20. 20. Blumberg RS, et al. Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J Immunol 1991;147:2518-2524.
21. 21. Pamer E, Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 1998;16:323-358.
22. + T cells. Science 1990;248:1227-1230.
23. + cytolytic T cells. Nature 1990;344:742-746.
24. + T cells. Cell 1992;71:1205-1214.
25. 2-microglobulin-dependent surface expression of functional mouse CD1.1. J Exp Med 1995;182:1913-1919.
26. + targets. J Immunol 1998;160:3681-3688.
27. +) T tells that express αβ T cell receptors in transporters associated with antigen presentation-1 null and thymus leukemia antigen positive mice. J Exp Med 1996;184:1579-1584.
28. + intestinal intraepithelial lymphocytes. J Immunol 1996;156:4209-4216.
29. 29. Teitell M, et al. Nonclassical behavior of the mouse CD1 class I-like molecule. J Immunol 1997;158:2143-2149.
30. 30. Zeng Z, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 1997;277:339-345.
31. 31. Brenner M, Porcelli S. Antigen presentation: a balanced diet. Science 1997;277:332.
32. 32. Joyce S, et al. Natural ligand of mouse CD1d1: cellular glycophosphatidylinositol. Science 1998;279:1541-1544.
33. α14 NKT cells by glycosylceramides. Science 1997;278:1626-1629.
34. 34. Couedel C, et al. Diverse CD1d-restricted reactivity patterns of human T cells bearing "invariant" AV24BV11 TCR. Eur J Immunol 1998;28:4391-4397.
35. 35. Brossay L. Naidenko O, Burdin N, Matsuda J, Sakai T, Kronenberg M. Structural requirements for galactosylceramide recognition by CD1-restritted NK T cells. J Immunol 1998;161:5124-5128.
36. 36. Brossay L, et al. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 1998;188:1521-1528.
37. + NK T lymphocytes. J Immunol 1998;161:3271-3281.
38. 38. Spada FM, Koezuka Y, Porcelli SA. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 1998;188:1529-1534.
39. 39. Castaño AR, et al. Peptide binding and presentation by mouse CD1. Science 1995;269:223-226.
40. 40. Lee DJ, Abeyratne A, Carson DA, Corr M. Induction of an antigen-specific, CD1-restricted cytotoxic T lymphocyte response in vivo. J Exp Med 1998;187:433-438.
41. 41. Tangri S, Brossay L, Burdin N, Lee DJ, Corr M, Kronenberg M. Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing. Proc Natl Acad Sci USA 1998;95:14314-14319.
42. 42. Behar SM, Podrebarac TA, Roy CJ, Wang CR, Brenner MB. Diverse TCRs recognize murine. CD1. J Immunol 1999;162:161-167.
43. 43. Bix M, Locksley RM, Natural T cells. Cells that co-express NKRP-1 and TCR. J lmmunol 1995;155:1020-1022.
44. - cells: new clues to their origin, specificity, and function. J Exp Med 1995;182:633-638.
45. + T cells: a new family of T cells. Immunol Today 1996;17:71-76.
46. - thymocytes. J Immunol 1991;147:2883-2891.
47. +8 single-positive thymocyte subpopulation that express a highly skewed T-cell antigen Vβ family. Proc Natl Acad Sci USA 1992;89:6506-6510.
48. + T cell subsets: a subset (Thy0) that secretes diverse cytokines and overexpresses the Vβ8 T cell receptor gene family. J Exp Med 1992;176:269-274.
49. + thymocytes selected by MHC class I molecules. Science 1994;263:1774-1778.
50. + T-cell antigen receptor α chain in mice. Proc Natl Acad Sci USA 1991;88:7518-7522.
51. + and CD4 8 T cells in mice and humans. J Exp Med 1994;180:1097-1106.
52. 52. Budd RC, Miescher GC, Howe RC, Lees RK, Bron C, MacDonald HR. Developmentally regulated expression of T cell receptor β chain variable domains in immature thymocytes. J Exp Med 1987;166:577-582.
53. 53. Fowlkes BJ, et al. A novel population of T-cell receptor αβ-bearing thymocytes which predominantly express a single Vβ gene family. Nature 1987;329:251-254.
54. + cells. J Immunol 1990;145:3209-3215.
55. 55. Seki S, Abo T, Ohteki T, Suguira K, Kumagai K. Unusual αβ-T cells expanded in autoimmune lpr mice are probably a counterpart of normal T cells in the liver. J Immunol 1991;147:1214-1221.
56. 56. Ohteki T, et al. Age-dependent increase of extrathymic T cells in the liver and their appearance in the periphery of older mice. J Immunol 1992;149:1562-1570.
57. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995;154:4333-4340.
58. 58. Yankelevich B, Knobloch C, Nowicki M, Dennert G. A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts. J Immunol 1989;142:3423-3430.
59. 59. Guy-Grand D, Cuenod-Jabri B, Malassis-Seris M, Selz F, Vassalli P. Complexity of the mouse gut T cell immune system: identification of two distinct natural killer T cell intraepithelial lineages. Eur J Immunol 1996;26:2248-2256.
60. 60. Eberl G, MacDonald HR. Rapid death and regeneration of NKT cells in anti-CD3ε-or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 1998;9:345-353.
61. + T lymphocytes. Science 1995;268:863-865.
62. 62. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, Van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1998;6:469-477.
63. 63. Park S-H, Roark JH, Bendelac A. Tissue-specific recognition of mouse CD1 molecules. J Immunol 1998;160:3128-3134.
64. 64. Natori T, Koezuka Y, Higa T. Agelaspins, novel α-galactosylceramides from the marine sponge Agelas mauritianus. Tetrahedron Lett 1993;34:5591-5592.
65. 65. Natori T, Morita M, Akimoto K, Koezuka Y. Agelaspins, novel antitumor and immunostimulatory cerebrosides from the marine sponge Agelas mauritianus. Tetrahedron 1994;50:2771-2784.
66. 66. Morita M, et al. Structure-activity relationship of α-galactosylceramides against B16 bearing mice. J Med Chem 1995;38:2176-2187.
67. 67. Nieda M, et al. Activation of human Vα24 NKT cells by an α-galactosylceramide in a CD1d-restricted and Vα24 TCR-mediated manner. Hum Immunol 1999;60:10-19.
68. 68. Cosgrove D, et al. Mice lacking MHC class II molecules. Cell 1991;66:1051-1066.
69. + T cells in major histocompatibility complex class II-deficient mice. Science 1991;253:1417-1420.
70. + thymocytes. J Exp Med 1994;180:395-399.
71. + cells in the liver of mice. J Exp Med 1994;180:699-704.
72. + T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone-marrow-derived cells. Proc Natl Acad Sci USA 1995;92:1200-1204.
73. + T cell development and early IL-4 production in CD1-deficient mice. Immunity 1997;6:459-467.
74. 74. Smiley ST, Kaplan MH, Grusby MJ. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 1997;275:977-979.
75. d. Proc Natl Acad Sci USA 1998;95:8199-8204.
76. +CD4 8 thymocytes by class I molecules expressed by hematopoietic cells. J Exp Med 1993;178:901-908.
77. + T cells by CD1 expressing cortical thymocytes. J Exp Med 1995;182:2091-2096.
78. + T cells acquire lymphokine secretion potentials during thymic maturation. Nature 1991;353:68-71.
79. 79. Yoshimoto T, Paul WE. CD4, NK1.1 T cells promptly produce interleukin 4 in response to in vivo challenge with anti CD3. J Exp Med 1994;179:1285-1295.
80. + T cells produce large amounts of IL 4 and IFN-γ upon activation by anti CD3 or CD1. J Immunol 1997;159:2240-2249.
81. 81. Kawano T, et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα24 NKT cells. Proc Natl Acad Sci USA 1998;95:5690-5693.
82. 82. Nakagawa R, et al. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an α galactosylceramide, KRN7000. Cancer Res 1998;58:1202-1207.
83. 83. Lanier LL. NK cell receptors, Annu Rev Immunol 1998;16:359-393.
84. + T cells upon NKR-Pl cross-linking. J Exp Med 1996;183:2391-2396.
85. + cells. J Immunol 1998;160:1158-1165.
86. + T cells. J Exp Med 1998;187:2109-2114.
87. +CD4 CD8 cells. J Exp Med 1994;179:1957-1972.
88. + αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J Immunol 1996;156:3366-3373.
89. 89. Cui J, et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 1997;278:1623-1628.
90. + lymphoid population capable of eliciting cytolysis against Fas-positive tumor cells. J Immunol 1997;159:2599-2605.
91. 91. Dao T, Mehal WZ, Crispe IN. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol 1998;161:2217-2222.
92. + T cells in IL-12-induced immune responses in vivo. J Immunol 1998;160:16-19.
93. 93. Leite-De-Moreis MC, et al. IL-4-producing NK T cells are biased towards IFN-γ production by IL-12. Influence of the microenvironment on the functional properties of NK T cells. Eur J Immunol 1998;18:1507-1515.
94. 94. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-793.
95. 95. Schmitz J, et al. Induction of interleukin 4 (IL-4) expression in T helper (Th) cells is not dependent on IL-4 from non-Th cells. J Exp Med 1994;179:1349-1353.
96. 112 response and in immunoglobulin E production. Science 1995;270:1845-1847.
97. 2-microglobulin independent and develop normally in the absence of IL-4 priming of T cells. J Immunol 1998;160:3299-3304.
98. 98. Morris SC, Lees A, Inman J, Finkelman FD. Role of antigen-specific T cell help in the generation of in vivo antibody responses. I. Antigen-specific T cell help is required to generate a polyclonal IgG1 response in anti-IgD antibody injected mice. J Immunol 1992;149:3836-3844.
99. 99. Holcombe HR, et al. Nonclassical behavior of the thymus leukemia antigen: peptide transporter-independent expression of a nonclassical class I molecule. J Exp Med 1995;181:1433-1443.
100. 100. Bix M, Liao NS, Zijlstra M, Loring J, Jaenisch R, Raulet D. Rejection of class I MHC deficient haemopoietic cells by irradiated MHC-matched mice. Nature 1991;349:329-331.
101. 101. Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991;253:199-202.
102. 102. Ghetie V, Hubbard JG, Kim JK, Tsen MF, Lee Y, Ward ES. Abnormally short serum half-lives of IgG in β2-microglobulin deficient mice. Eur J Immunol 1996;26:690-696.
103. 103. Junghans RP, Anderson CL. The protection receptor for IgG catabolism is the β2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci USA 1996;28:5512-5516.
104. + T cells are not essential for T helper cell 2 immune responses. J Exp Med 1996;184:1295-1304.
105. 105. Zhang Y, Rogers KH, Lewis DB. β2-Microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J Exp Med 1996;184:1507-1512.
106. + T cells do not prevent the development of an IgE-dependent allergic phenotype. Clin Exp Allergy 1998;28:950-955.
107. 107. Korsgen M, et al. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med 1999;189:553-562.
108. + T cells that promptly produce interleukin 4. Proc Natl Acid Sci USA 1995;92:11931-11934.
109. + T cell-defective IL 4 production in the non-obese diabetic mouse. Int Immunol 1996;8:1751-1758.
110. +-like thymocytes in the NOD mouse. Eur J Immunol 1996;26:2989-2998.
111. 111. Beutner U, Launois P, Ohteki T, Louis JA, MacDonald HR. Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production. Eur J Immunol 1997;27:928-934.
112. 2-microglobulin knockout and SJL mice. J Immunol 1998;160:2649-2654.
113. 113. Lehuen A, et al. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J Exp Med 1998;188:1831-1839.
114. 114. Takeda K, Dennert G. The development of autoimmunity in C57BL/6 Ipr mice correlates with the disappearance of natural killer 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J Exp Med 1993;177:155-164.
115. + NK T cells associated with disease development in autoimmune-prone mice. J Immunol 1996;156:4035-4040.
116. 116. Sumida T, et al. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J Exp Med 1995;182:1163-1168.
117. 117. Wilson SB, et al. Extreme Th 1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 1998;391:177-181.
118. + effector function against intracellular infection. J Exp Med 1996;184:131-139.
119. + TCR α/β intermediate liver lymphocytes are down-regulated by Listeria monocytogenes. Eur J Immunol 1995;25:3321-3325.
120. 120. Schofield L, et al. CD1d-restricted immunoglobulin G formation to GP1-anchored antigens mediated by NKT cells. Science 1999;283:225-229.
121. + thymocyte population associated with intact Fas antigen expression on the target. J Exp Med 1994;180:423-432.
122. 122. Chiu Y-H, et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med 1999;189:103-110.s